New drug combo targets tough prostate cancers in understudied groups
Disease control
Terminated
This study was designed to test a combination of two drugs (niraparib and abiraterone plus prednisone) in Hispanic/Latino and Black patients with metastatic hormone-sensitive prostate cancer that has specific gene mutations. The goal was to see if this treatment could lower PSA l…
Phase: PHASE2 • Sponsor: Qian Qin • Aim: Disease control
Last updated May 03, 2026 06:48 UTC